Skyler HicksAssociate Sheppard, Mullin, Richter & Hampton LLPWebsitewww.sheppardmullin.comOrganization ProfileFull ProfileConnectEmail415-774-2907 Professional Biography Skyler Hicks is an associate in the Business Trial Practice Group in the firm's San Francisco office. More Legal and Business Bylines From Skyler Hicks What the Third Circuit’s Looming Decision Regarding Whether College Athletes Can Constitute “Employees” Will Mean for Universities and Employers of Unpaid Student Interns - (Posted On Wednesday, January 18, 2023) Blockchain Game Developers and FinCEN: When are State Money Transmission Laws Applicable? - (Posted On Tuesday, October 04, 2022) What the Future Holds for Esports Gambling - (Posted On Thursday, March 31, 2022) Navigating the Sports Biometrics Boom - (Posted On Thursday, March 10, 2022) Looking Ahead to Tougher Merger Guidelines and Enforcement - (Posted On Friday, February 04, 2022) What Brands Can Expect from College Sports’ Ever Evolving NIL Landscape - (Posted On Thursday, January 20, 2022) Supreme Court Set To Resolve Circuit Split Concerning Foreign Arbitration Discovery Rules - (Posted On Friday, December 17, 2021) Current Legal Analysis October 2024 Bounty Hunter Plaintiff Claims by: Sophia B. Castillo , Mitzi Ng Clark Mississippi Gaming Commission Meeting Report (November 2024) by: Thomas B. Shepherd III , Christopher S. Pace December 2024 Visa Bulletin Shows Final Action Date Advances for India Under EB-2 and EB-3 Categories by: Sidra E. Cheema UAE Law on the Enforceability of Unilateral Arbitration Agreements by: Jennifer Paterson , Mohammad Rwashdeh EPA Designation of PFAS as Chemicals of Special Concern Expands TRI Reporting Requirements for Nearly 200 PFAS by: Jeffrey J. Parker , Olivier F. Theard Stay Off the Naughty List: Mistakes to Avoid with Holiday Gift Giving by: Michael K. Mahoney Upcoming Events Dec 10 2024 Legal AI Week 2024 Nov 25 2024 2024 Election: Impact on the Health Care Legal and Policy Landscape Webinar Dec 4 2024 GLP-1 Drugs: What's Next after FDA's Resolution of Drug Shortages Dec 4 2024 TSCA 30/30 - December 4, 2024 Dec 4 2024 REACH 30/30 - 04 December 2024 Dec 5 2024 Home Care Industry Update Dec 5 2024 Annual Review: Non-compete and Trade Secret Protection for Employers Dec 11 2024 2025 Annual Reporting & Proxy Season Update Print
